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In  vitro  cell  proliferation,  cell  cycle  arrest  and  induction  of  apoptosis  were  investigated,  using  three
human  head  and  neck  squamous  cell  carcinoma  (HNSCC)  cell  lines  (OSCC-3,  SCC-61,  and  SQ-20B).
Aqueous  extracts  of Camellia  sinensis,  Ilex  paraguariensis,  and  Ardisia  compressa  were tested  and  (−)
epigallocatechin-3-gallate  (EGCG)  was  used  for comparison.  For  EGCG  the  IC50 values  were  between  80
and  166 M  and  for the extracts  among  75  and  505  M eq.  (+)  catechin,  with  C.  sinensis  demonstrating
dominant  cytotoxicity.  There  was  not  a correlation  between  antioxidant  capacity  and cytotoxicity.  Flowamellia sinensis
rdisia compressa
lex paraguariensis
olyphenols
hemoprevention
ead and neck squamous carcinoma cells
cytometry  analysis  revealed  similarities  in  response  for  EGCG  and  C.  sinensis.  The A.  compressa  extract
altered  DNA  distribution  (P < 0.05)  and  was  the  most  effective  in induction  of  apoptosis  via  caspases
(P  < 0.05).  Not all HNSCC  cells  tested  responded  to the same  preventive  agents.  The fact  that  A.  com-
pressa  inhibits  HNSCC  cell  proliferation  makes  this  aqueous  extract  a potential  source  of  chemopreventive
agents.
© 2016  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC. Introduction
Head and neck squamous cell carcinoma (HNSCC) is an aggres-
ive epithelial malignancy and accounts for about 640,000 new
ases of cancer worldwide and approximately 355,000 deaths
nnually [22]. In the United States approximately 45,780 new
ases are expected in 2015 with an estimated of 8650 deaths for
NC of the oral cavity, pharynx, and larynx. Both morbidity and
ortality rate are higher in men  than women [1]. Exposure to
obacco and its smoke, and excessive alcohol consumption are the
rimary risk factors associated with HNSCC carcinogenesis [17].
arious other factors including infections with Epstein-Barr virus,
ast infections with human papilloma viruses (HPV16 and HPV18),
hewing betel nut or shamma, dietary factors, poor oral hygiene,
ccupational hazards and possibly infections with human immun-
deﬁciency virus, etc., have been also shown to be associated with
tiology of HNSCC [25]. The 5-year survival rate (have remained
∗ Corresponding author. Fax: +52 958 5843078
E-mail address: marcoram@angel.umar.mx (M.V. Ramirez-Mares).
1 Present address: College of Agriculture, Food Science & Sustainable Systems,
entucky State University, Chappell Building, Room 104, 400 East Main St., Frankfort,
Y 40601, USA.
ttp://dx.doi.org/10.1016/j.toxrep.2016.01.013
214-7500/© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
approximately 50% for decades) and quality of life have not been
improved signiﬁcantly because these cancers arise in physically
compact and anatomically complex sites (larynx, pharynx, oral
cavity and tongue), the so frequent presentation with advanced
stage disease (Stage I cancers have an ∼80% 5-year survival while
Stage IV have an ∼20%), the diversity of histologic types of tumors,
the high recurrence rate after surgical removal, and additionally
the extremely frequent development of multiple additional second
primary tumors (STPs) further worsen the prognosis of patients
with HNSCC [41,40]. In HNSCC multiple genetic and epigenetic
events are highly associated with its pathogenesis, including the
dysregulation of the cell growth, cell cycle, apoptosis and angio-
genesis. The mutation of the p53 tumor suppressor gene (occur
in 47% to 62% of HNSCC), inactivation of the cyclin-dependent
kinase 4 (CDK4) inhibitor p16 and overexpression (80–90% of
HNSCC) of epidermal growth factor receptor (EGFR), have been
considered as critical transforming events of the disease [43,27,2].
The numerous genetic mutations in regulatory genes provide a
strong rationale to targeting speciﬁc molecular pathways for a
chemopreventive approach to the control of the HNSCC carcino-
genesis.
Of all strategies involving chemoprevention, the induction of
cell cycle arrest and cancer-cell-selective apoptosis by polyphe-
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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ols has been receiving considerable attention as an approach to
limination of malignant cells [20]. Polyphenols may  derive their
reventive effect against HNSCC by coming into direct contact with
issues before being absorbed or metabolized. For instance, Camel-
ia sinensis (green tea, GT) contains a high amount of antioxidant
olyphenols, most notably (−) epigallocatechin-3-gallate (EGCG),
nd regular GT consumption is linked to a reduced risk for various
ypes of cancer including colorectal [11], prostate [23] and HNSCC
5,19] cancer. Yerba mate (MT), a tea-like infusion of Ilex paraguar-
ensis consumed regularly in many parts of South America, is sold in
ommercial herbal preparations as antirheumatic with anticanceri-
en properties [36,38,15]. Aqueous extracts of Ardisia compressa,  a
ative plant of the Paciﬁc Coast of Mexico have been used to treat
iver cancer [39]. Medicinal properties of ardisia tea (AT) including
ntigenotoxicity, anticytotoxicity, and antioxidant activities have
een previously summarized [24]. Despite the widespread con-
umption of these herbal extracts, very little is known of their
hemopreventive properties against HNSCC. The objective of this
nvestigation was  to compare the in vitro antitumor capacity of
. sinensis, I. paraguariensis and A. compressa extracts and EGCG
gainst human head and neck squamous carcinoma cells, by assess-
ng their cytotoxicity, cell proliferation, antioxidant capacity, cell
ycle distribution and apoptosis induction.
. Materials and methods
.1. Preparation of aqueous extracts
A. compressa leaves were collected from paciﬁc coast of Mexico
Michoacan State), while ﬁne dried leaves of I. paraguariensis and
. sinensis (Romance and Lipton brand, respectively) were obtained
rom local market. Dry leaves (2.7 g) of AT, MT,  and GT were soaked
eparately in 250 ml  boiling water and allowed to stand for 10 min.
he mixture of each tea was cooled to room temperature and ﬁl-
ered (0.45 m nylon ﬁlter), freeze-dried and kept at −20 ◦C in a
lastic container sealed with Paraﬁlm and protected from light.
revious to use, the freeze-dried materials (FD) or instant teas were
issolved in double distilled water (ddH2O) (1 mg/100 l), ﬁltered
ith a 0.22 l syringe top ﬁlter and serially diluted in serum-free
edium.
.2. Total polyphenol content of aqueous extracts
All chemicals and reagents used in this study were purchased
rom Sigma–Aldrich (St. Louis, MO)  unless noted otherwise. The
otal polyphenol content of the aqueous extracts was measured
s described by [35]. This method is based on the reduction
f Folin Ciocalteu reagent by the electrons from the phenols.
rieﬂy, 1 ml  1 N Folin-Ciocalteu reagent and 1 ml  sample were
ixed and allowed to stand for 2–5 min, and then ml  of 20%
a2CO3 solution were added and allowed to stand for 10 min
efore measuring the absorbance at 730 nm using a Beckman
U® 640 spectrophotometer (Coulter Inc., Fullerton, CA). The
otal polyphenol content was expressed as g equivalents of
+) catechin per ml  of aqueous extract. The equation of the
tandard curve used was: y = 0.027x − 0.50, r2 = 0.98 (where, y:
bsorbance at 730 nm;  x: polyphenol concentration; r2: correlation
oefﬁcient).
.3. Antioxidant capacity assayThe oxygen radical absorbance capacity (ORAC) assay [37] was
sed to assess antioxidant capacity by measuring the protection
f the extracts and EGCG on -phycoerythrin (-PE) ﬂuores-
ence in the presence of free radicals generated by 2,2′-azobisgy Reports 3 (2016) 269–278
(2-amidinopropane) dihydrochloride (AAPH). The assay was car-
ried out in black-walled 96-well plates (Fisher Scientiﬁc, Hanover
Park, IL). Each well had a ﬁnal volume of 200 l. The following
reactants were added in the order: 25 l of 75 mM phosphate
buffer pH 7; either 25 l Trolox standard (1 mM ﬁnal concentra-
tion) or sample (1.0–3.0 g eq. (+)-catechin/ml); 100 l of -PE
(1.52 nM ﬁnal concentration); and 50 l of AAPH (41.6 mM ﬁnal
concentration). As a blank, 25 l of 75 mM phosphate buffer pH 7
was added instead of Trolox or samples. Immediately after addi-
tion of AAPH, plates were placed in a FL × 800 ﬂuorescence plate
reader (Bio-Tek Instruments, Winooski, VT), set with excitation
ﬁlter 530/25 nm and emission ﬁlter 590/35 nm,  and then read
every 2 min  for 2 h to reach a 95% loss of ﬂuorescence. Final ﬂu-
orescence measurements were expressed relative to the initial
reading. Results were calculated based on the differences in the area
under the -PE decay curve between the blank and a sample, and
expressed as micromoles of Trolox equivalents (TE)/g dry leaves
(DL). Trolox (1–4 M)  was  used as a standard (y = 3.35x + 0.42,
r2 = 0.98).
2.4. In vitro-assays of cytotoxicity and proliferation
OSCC-3 and HaCaT cell lines were cultured in Dulbecco’s mod-
iﬁed Eagle’s medium plus Ham F12 (DME/F12) mixture (1:1)
medium containing 10% fetal bovine serum (FBS). SCC-61 and
SQ-20B cells were cultured in the same medium with added hydro-
cortisone (0.4 g/ml). All cells were maintained at 37 ◦C in 5% CO2
atmosphere with 95% humidity. Cultures were passaged as needed,
and the culture medium was  changed every other day. SQ-20B,
HaCaT, SCC-61 and OSCC-3 cells were used because one of our
long-term objectives was to determine the role of herbal teas in
the prevention of HNSCC. All four different cell types were used
as a starting point and emphasis was  given to SCC-61, SQ-20B and
OSCC-3 for the study of apoptosis.
Cells were plated onto 96-well plates during exponential growth
at a density of 5 × 104 cells/ml, 100 l/well. After 24 h, cells were
treated with 100 l serial concentrations of EGCG (AG Scientiﬁc,
San Diego, CA), or GT, MT  and AT. After incubating for 48 h, the
medium containing the extracts or EGCG was discarded and the
plates washed twice with phosphate-buffered saline (PBS). PBS was
used as a control. One hundred microliters of serum-free medium
containing 10 l of cell counting kit 8 (CCK-8) solution (Dojindo
Molecular Technologies, Gaithersburg, MD)  were added to each
well of the plate. The amount of the formazan dye generated by
the activity of dehydrogenases within cells was  directly propor-
tional to the number of living cells, ensuring a linear relationship
between absorbance at 450 nm and the cell number. The plate was
incubated for 2 h and the absorbance measured at 450 nm using a
microplate reader interfaced with a computer. At the end of each
experiment, cytotoxicity and proliferation were calculated for each
extract and EGCG according to the protocol described by [33]. The
following parameters were used:
IC50—the concentration of the agent that inhibits growth by 50%,
is the concentration at which (T/C) × 100 = 50, where T = number of
cells, at time t of treatment; C = control cells at time t of treatment.
GI50—the concentration of the agent that inhibits growth by
50%, relative to untreated cells, is the concentration at which
([T − T0]/[C − T0]) × 100 = 50, where T and C are the number of
treated and control cells, respectively, at time t of treatment and
T > T0; T0 is the number of cells at time zero.
GI50 considers cells at time zero and IC50 does not.
TGI—the concentration of the agent that completely inhibits cell
growth, is the concentration at which T = T0.
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LC50—the concentration of the agent that results in a net loss of
0% cells, relative to the number at the start of treatment, is the
oncentration at which ([T − T0]/T0) × 100 = −50; T < T0.
.5. Cell cycle distribution
All reagents for cell staining were obtained from Molecular
robes (Eugene, OR). Since ﬂuorescence of propidium iodide-
tained cells is directly proportional to their nuclear content, it was
sed to measure the DNA content of each cell. Flow cytometric anal-
sis of DNA content was  conducted on all four cell lines with and
ithout test compounds or extracts at IC50 levels. In addition to
GCG, treatments with etoposide, a known inducer of cell cycle
rrest in certain cell types, was included at IC50 levels: 0.79 M,
aCaT; 0.44 M,  SCC-61; 2.95 M,  SQ-20B; and 3.39 M,  OSCC-
. For ﬂow cytometric analysis, cells were seeded at 1.25 × 105.
fter 24 h, the cells were treated with the extracts. At 48 h cells
ere washed with PBS then trypsinized, diluted with twice their
olume of culture medium, then centrifuged for 5 min  at 2000 × g
nd the medium discarded. Propidium iodine (PI) cell staining was
arried out as described previously [44] using 375 l of staining
olution [300 l H2O + 37.5 l sodium citrate (10 mg/ml) + 3.75 l
riton X-100 (10%, v/v) + 18.75 l PI (1 mg/ml)], followed by 15 l
eoxyribonuclease-free ribonuclease A (7 units/ml). Cells were
rieﬂy vortex and then tilted in staining solution every 3–5 min
or 45 min  at 4 ◦C. Subsequently, 625 l of cold PBS were added
o each tube, and the cells ﬁltered through 53 m nylon mesh, fol-
owed by incubation on ice for half an hour. Cells were again ﬁltered
hrough the nylon mesh, prior to ﬂow cytometric analysis. Cell cycle
easurements were done using an EPICS XL ﬂow cytometer (Coul-
er Electronics, Hileah, FL, U.S.A.) with an excitation wavelength
f 488 nm and emission at 670 nm.  Ten thousand events were ana-
yzed per sample. DNA content was determined by ModFit software
Verity Software House, Topsham, ME).
.6. Apoptosis
Two types of cell stain, Hoechst 33342 and propidium iodine
ere used to distinguish apoptotic cells from dead or normal cells.
oechst 33342 preferentially stains apoptotic cells over normal
ells due to the presence of condensed chromatin, whereas pro-
idium iodine stains dead cells, but not apoptotic or normal cells.
fter treatment, cells were trypsinized, washed and re-suspended
n PBS. Cells were stained according to the manufacturer’s instruc-
ion. Cells were incubated on ice for 20 min  following addition of
0 l of Hoechst 33342 trihydrochloride, trihydrate (100 g/ml)
nd 10 l of PI (100 g/ml) to the cell suspension, prior to analysis.
luorescence of Hoechst and PI was measured by ﬂow cytometry
sing a MoFlo instrument (Cytomation, Fort. Collins, CO, U.S.A.),
quipped with a Coherent Innova 90 C laser with an excitation
avelength of 488 nm (PI) and a Coherent I90 with an excitation
avelength of 351 nm (Hoechst). Fluorescence emission for PI was
easured at 670 nm with a 40 nm band pass ﬁlter and for Hoechst at
50 nm with a 65 nm band pass ﬁlter. A minimum of 10,000 events
ere acquired per sample. Data were analyzed using Summit V3.1
oftware (Cytomation).
.7. Detection of caspase activity
A distinctive feature of apoptosis is the activation of caspase
nzymes, the name applied to cysteine aspartic acid-speciﬁc pro-
eases. Caspases are key components of the apoptotic machinery
f cells, participating in an enzyme cascade that results in cel-
ular disassembly. The Vybrant FAM Poly Caspases Assay Kit for
ow cytometry (Molecular Probes, Eugene, OR, U.S.A.) allows one
o detect these key apoptotic events. This method detects a ﬂuores-gy Reports 3 (2016) 269–278 271
cent inhibitor of caspases (FLICA) bound to the enzymatic reactive
center of activated caspases. The reagent contains a ﬂuoromethyl
ketone (FMK) moiety that covalently associates with a caspase-
speciﬁc amino acid sequence that includes reactive cysteine at
the active site of caspases and inhibits further enzymatic activity.
Unbound FLICA reagent diffuses out of the cell and is washed away.
A carboxyﬂuorescein group (FAM) is attached as a reporter.
To further investigate the mechanism of ardisia-induced apo-
ptosis, experiments were conducted using the Vybrant FAM Poly
Caspases assay to detect caspase activity in AT-treated cells. Cells
were prepared and exposed to AT for 24 or 48 h. Cell detach-
ment was  achieved by trypsinization, followed by deactivation of
the enzyme with FBS containing medium. Cells were centrifuged
for 5 min  at 2000 × g, and re-suspended in medium at a density
of 1.0 × 106 cells/ml. To 300 l of the cell suspension, 10 l of a
solution of ﬂuochrome-labeled caspase inhibitors (FAM-VAD-FMK
FLICA) was  added according to the manufacturer’s instruction. Cells
were incubated for 45 min at 37 ◦C and 5% CO2. After the incuba-
tion, 2 ml  of washing buffer was added to each tube and cells were
centrifuged for 5 min  at 2,000 rpm. The supernatant was aspirated
immediately after centrifugation, and 1 ml  of fresh washing buffer
was added before another centrifugation and removal. Finally, 1 ml
of washing buffer was  added to each tube, and cells were then re-
suspended. Prior to analysis, 10 l of propidium iodine (100 g/ml)
was added. Measurements of cell samples were conducted with
the EPICS XL ﬂow cytometer (488 nm excitation wavelength) with
525 nm band pass emission ﬁlter for FLICA ﬂuorescence and 670 nm
band pass emission ﬁlter for PI ﬂuorescence. At least 10,000 events
were analyzed per sample. The remaining green ﬂuorescent signal
was considered a direct measure of the amount of active caspases
that were present at the time the inhibitor was  added.
2.8. Statistical analysis
Results are expressed as the mean ± SD of values obtained in
at least triplicate measurements from three different experiments.
Fisher’s least signiﬁcant difference test was performed for mean
separation of DNA distribution and apoptosis induction. P values
less than 0.05 were considered signiﬁcant. When more than two
means were compared, signiﬁcance was  determined by one-way
analysis of variance followed by pairwise comparisons using the
Tukey test. Analysis on sigmoidal dose-response was performed
by non-linear regression (curve ﬁt) using the GraphPad Prism ®
software.
3. Results
Endpoint parameters were calculated for each individual cell
line including the GI50, which is deﬁned as the extract concen-
tration that inhibits growth by 50%; the TGI, which is the lowest
extract concentration that totally inhibits cell growth; and the LC50,
which is the lowest concentration that kills 50% of cells. All of the
cell lines responded to extract treatments in a dose-dependent
manner. Table 1 depicts the cytotoxicity and proliferation values
after 48 h exposure of the various HNSCC cell lines to the different
extracts. Comparison is made with the positive control EGCG. The
IC50 value for EGCG against immortalized keratinocytes (116.1 M)
was intermediate between the oral squamous cell lines studied, SQ-
20B (81.3 M eq. (+) catechin), SCC-61 (123.0 M eq. (+) catechin)
and OSCC-3 (166.0 M eq. (+) catechin). In general, GT was one of
the most potent of all extracts tested, and exhibited cytotoxicity
against oral cancer cells in a clearly dose-dependent manner, sim-
ilar to that of EGCG. GT had the second best IC50 in two of the cell
lines tested. GT required an average of 142 M eq. (+) catechin to
obtain IC50 for all the cells tested and EGCG 121 M.
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Table 1
Cytotoxicity and inhibition of proliferation of HaCaT, SCC-61, SQ-20B and OSCC-3 cells after 48 h exposure to (−) epigallocatechin-3-gallate (EGCG), and hot water extracts
of  Camellia sinensis (GT), Ilex paraguariensis (MT) and Ardisia compressa (AT).*
HaCaT
EGCGm (M) GT (M eq. (+) catechin) MT  (M eq. (+) catechin) AT (M eq. (+) catechin)
IC50 116.1a 99.6a 99.9a 504.5b
GI50 100.0a,b 85.4a 84.2a 125.0b
TGI 177.9b 191.5b 94.7a 239.0c
LC50 237.1b 270.8c 118.7a >222.3b
SCC-61
EGCG (M) GT (M eq. (+) catechin) MT (M eq. (+) catechin) AT (M eq. (+) catechin)
IC50 123.0b 132.6b 74.8a 453.4c
GI50 79.4a 107.8a,b 94.3a 235.3c
TGI 133.4 b 135.0b 105.8a >295.9c
LC50 177.8 b 170.9b 118.7a >295.9c
SQ-20B
EGCG (M) GT  (M eq. (+) catechin) MT (M eq. (+) catechin) AT (M eq. (+) catechin)
IC50 81.3a 152.2b 213.9c 355.2d
GI50 100.0a 170.8b 186.4b 296.0c
TGI 199.5a 303.7b 209.1a >592.0c
LC50 251.2a 340.8b 263.2a >592.0c
OSCC-3
EGCG (M) GT (M eq. (+) catechin) MT (M eq. (+) catechin) AT (M eq. (+) catechin)
IC50 166.0b 184.3b 266.0c 112.7a
GI50 141.3b 170.9b 237.1c 73.0a
TGI 173.8b 191.5b 266.0c 148.5a
LC 251.1b 227.7b 298.7c 166.4a
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* See Section 2 for details. Values are the average of three independent experim
ifferent (P < 0.05).
Potency of MT  was in a narrow range across all cell lines tested
nd for all parameters evaluated. The IC50, GI50, TGI, and LC50 val-
es of MT  for HaCaT were 99.9, 84.2, 94.7, and 118.7 M eq. (+)
atechin, respectively. A similar relationship between IC50, GI50,
GI, and LC50 values was seen for all three other cell lines, although
CC-61 required lower concentration of MT  (74.8 M eq. (+) cate-
hin) to achieve reduction in cell growth than did SQ-20B (214 M
q. (+) catechin), and OSCC-3 (266 M eq. (+) catechin).
A relatively small amount of AT was necessary to inhibit 50%
roliferation of OSCC-3 (112.7 M eq. (+) catechin), however higher
oncentrations were required to inhibit proliferation of the other
wo malignant cells. In contrast to other cell lines, where MT  was
ost potent, AT inhibited proliferation of OSCC-3 cells with the
reatest potency. The IC50 for AT was substantially greater for
aCaT, SCC-61 and SQ-20B (504.5, 453.4, 355.2 M eq. (+) cate-
hin, respectively) than for OSCC-3 cells (112.7 M eq. (+) catechin).
ifferences in morphology of OSCC-3 cells were observed among
T-treated (112.7 M eq. (+) catechin) and control cells by light
icroscopy. As shown in Fig. 1, the most visible changes observed
n AT-treated cells included cell shrinkage, extensive detachment
f the OSCC-3 cells from the cell culture substratum, and single cells
r small clusters of cells. These changes are characteristics of apop-
otic cells [13], and became visible after 24 h of AT-treatment, but
ere absent in control cells. The morphological changes become
ore notable with increased time (48 h) of AT-treatment (112.7 M
q. (+) catechin). These observations suggested that OSCC-3 cells
reated with AT detached from the substratum and died by apo-
tosis.
The antioxidant capacity and total polyphenol content of GT, MT
nd AT are summarized in Table 2. When the antioxidant capacity
as expressed as mol  TE/ml or as mol  TE/g DL, GT with the
ighest total polyphenol content, showed the highest antioxidantperformed in triplicate. Different letters in a row, per type of cell, are statistically
capacity as ORAC values. AT (333.5 mol  TE/g DL or 4.9 mol  TE/ml)
had signiﬁcantly lower ORAC values than MT  (1238.9 mol  TE/g
DL or 17.4 mol  TE/ml) and GT (1345.9 mol  TE/g DL or 20.1 mol
TE/ml). The antioxidant values obtained in this study agree with the
range of ORAC values reported for other herbal aqueous extracts
(235–1526 mol  TE/g DL) [37]. AT, MT,  and GT had signiﬁcantly
different total polyphenol contents (P < 0.001). AT showed the low-
est value (36.78 ± 1.07 mg  eq. catechin/g DL) and GT the highest
(137.19 ± 5.79 mg  eq. catechin/g DL).
Fig. 2 depicts the effects of the various extracts on cell cycle
distribution. Although the overall pattern of cell cycle distribution
remained similar, signiﬁcant differences in DNA distribution were
found among treatments. AT caused a small but signiﬁcant arrest
of the cell cycle for all cell lines; there was  accumulation of SCC-61,
SQ-20B and OSCC-3 cells in the G2/M phase and in phase G0/G1 for
the HaCaT cells. Excitingly the treatment of the SCC-61, SQ-20B and
OSCC-3 cells with etoposide arrested similarly the cycles in G2/M
phase, but in a more marked way. There was  little or no effect by
MT.  Untreated SCC-61 cells revealed a distribution of cells in G0/G1
(54.1%), in S (36.5%), and G2/M (9.4%), EGCG and GT arrested these
cells in G0/G1. The cell cycle of the OSCC-3 cells was  arrested in
phase G2/M by the treatment with either EGCG or GT.
The results of induction of apoptosis on HNSCC by etoposide,
EGCG, GT, MT  and AT are shown in Fig. 3. Although EGCG caused
signiﬁcant induction of apoptosis, in OSCC-3 cells (33.2%), it had
less effect on other cell types with only a small number of apop-
totic cells observed in SCC-61 (20%), SQ-20B (10%) and HaCaT (15%).
GT was capable of inducing apoptosis in OSCC-3 and SCC-61 cells
(27.8 and 42.7% respectively), while little or no effect was  observed
on SQ-20B and HaCaT cells. MT  signiﬁcantly decreased the percent-
age of live HaCaT and SCC-61 cells and increased the proportion of
apoptotic cells. Of all extracts tested, AT was  found to be the most
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Fig. 1. Effect of AT on OSCC-3 cell histomorphology. (A) Control, 24 h; (B) treated with 112.7 M eq. (+) catechin AT, 24 h; (C) control, 48 h; (D) treated with 112.7 M eq. (+)
catechin AT, 48 h (original magniﬁcation, ×32).
Table 2
Antioxidant capacity and total polyphenol content of Camellia sinensis (GT), Ilex paraguariensis (MT) and Ardisia compressa (AT), using ORAC.
Aqueous extract ORAC valued,e Total polyphenol content
(mol  Trolox/ml) (mol  Trolox/g DL) (mg equivalents of (+) catechin/g DL)
GT 20.1 ± 0.9b 1345.9 ± 60.0b 137.19 ± 5.79c
MT 17.4 ± 0.8b 1238.9 ± 55.7b 82.13 ± 3.83b
AT 4.9 ± 0.1a 333.5 ± 8.2a 36.78 ± 1.07a
DL = dried leaves.
d Antioxidant capacity relative to 1 M Trolox. Values are the average of three independent extract preparations.
e Values with different letters in the same column are statistically different, P < 0.001.
Fig. 2. Cell cycle distribution (%) of SCC-61, HaCaT, SQ-20B and OSCC-3 exposed to etoposide, EGCG, GT, MT or AT for 48 h; see Section 2 for details. Values are means ± SD
from  three independent experiments performed in triplicate. Bars with different letters are statistically different from the control (PBS) (P < 0.05) for each cell cycle stage, 
G0/G1;  S;  G2/M, within treatments. IC50 concentrations were used and these differed depending on extract and cell line tested (see Table 1).
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xperiments performed in triplicate. *Statistically different from PBS (P < 0.05) for e
ro-apoptotic, and the percent of apoptotic cells was  44.3% (OSCC-
), 35.1% (SQ-20B), 43.0% (SCC-61), and 48.9% (HaCaT). These results
ndicated that AT was capable of altering, to various degrees, cell
ycle distribution and producing apoptosis.
Caspases were activated in HNSCC cells although the differ-
nce in the degree of activation varied with treatment. Activation
f caspases was observed in 39% and 35% of SQ-20B and OSCC-3
ells respectively, 48 h after exposure to IC50 concentration of AT
Fig. 4A). For both cell lines, the activation of caspases in untreated
ells was 1.4 and 1.3%, respectively. In contrast, caspases activation
as evident in only 20% of SCC-61 cells and signiﬁcantly greater
han control cells. Fig. 4B presents the number of dead, late apop-
otic, apoptotic, and alive cells in AT treated for 48 h, AT signiﬁcantly
ecreased the percentage of live OSCC-3, SCC-61 and SQ-20B cells
nd increased the proportion of late apoptotic and apoptotic cells,
n comparison to the untreated cells (Fig. 4C). HaCaT cells were not
ncluded in this experiment due to the low AT effect on cytotoxicity.
. Discussion
This investigation evaluated the anticancer potential of GT, MT
nd AT by assessing their chemical composition and their biologi-
al properties in an in vitro model. The cells used were all derived
rom human oral cavity squamous cell carcinomas (HaCaT, SCC-
1, SQ-20B and OSCC-3). As such, they are all histologically very
imilar, the presumed genetic differences may  explain why  some
re more and some are less responsive. This would be an interest-
ng avenue of investigation, for instance, correlate their response
o agents versus genetic/gene expression proﬁle. HaCaT cells are a
pontaneously transformed human skin keratinocyte cell line; they
re premalignant and therefore are frequently used as a model to
ompare with malignant cell lines. HaCaT cells are analogous to
ysplasia since they have a mutant p53, immortal, but do not formtes, and HNSCC cells. Rapidly proliferating HaCaT and three HNSCC cells; SCC-61,
T (AT: IC20 for SCC-61 and OSCC-3). Values are means ± SD from three independent
alive or apoptotic cells.  alive cells,  apoptotic cells.
tumors. The SCC-61 line is characterized by its radiosensitivity and
is a wild-type p53. The SQ-20B is a squamous cell carcinoma of lin-
eage derived from an explant from the oral cavity, harboring a tp53
mutant allele and has been reported to express a functional p53
protein [31]. The oral squamous cell carcinoma cells (OSCC-3) are
representative of a particularly aggressive epithelial malignancy.
EGCG, a major polyphenolic constituent of GT, was used as
a positive control in this study, partly because researchers have
investigated its role in inducing apoptosis in HNSCC cells while no
affecting normal cells [19]. An IC70 for EGCG against YCU-H-891, a
nasopharynx carcinoma cell line has been reported to be 21.8 M
after 72 h exposure [32]. Lin et al. treated three HNSCC cell lines
(SAS, Cal-27 and Ca9-22) with EGCG during 24 h and reported IC50
values from 6 to 18 M [29]. In the present study, the IC50 val-
ues for EGCG on HSNCC cell lines and immortalized keratinocytes
after 48 h were considerably greater (from 82 to 166 M).  However,
the present discrepancy might have stemmed from differences in
duration of chemical exposure, assay types, different cell number,
working volume and above all, cell types and their stage of malig-
nancy [12]. In fact, a wide range for the IC50 for EGCG has been
reported for different oral cancer cell types (1–200 M)  [10]. HaCaT
cells responded to treatments with EGCG in a dose-dependent man-
ner, and the IC50 value obtained fell in the range of concentrations
reported to activate extracellular signal-regulated kinase, p38 and
c-Jun NH2-terminal kinase [6]. EGCG is also known to diminish 2,2′-
azobis (2-amidinopropane) dihydrochloride cyclooxygenase-2 and
p38 activation in HaCaT. Although the concentrations reported pre-
viously [8] were lower than the doses having signiﬁcant effects in
this study.Treatments with GT resulted in loss of cell growth in a dose-
dependent manner, and the overall shapes of the curves were very
similar to those for EGCG. Indeed, the similarities between the two
became even more apparent when the concentration of GT  was
M.V. Ramirez-Mares et al. / Toxicology Reports 3 (2016) 269–278 275
F ere tr
4 SCC-3
i
c
u
e
a
E
w
i
i
S
c
T
c
o
m
i
c
kig. 4. (A) Caspase activation by Ardisia compressa extract in HNSCC cell lines. Cell w
8  h, data are shown as percent of the total number of tumorogenic cells (SCC-61, O
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onverted into (+) catechin equivalents. For example, the IC50 val-
es of EGCG and GT against SCC-61 were 123.0 M,  and 132.6 M
q. (+) catechin, respectively, while the LC50 values were 177.8 M
nd 170.9 M eq. (+) catechin for this cell line. Moreover, GT and
GCG cytotoxicity values against two cell lines, HaCaT and OSCC-3,
ere also very similar. These ﬁndings clearly indicate that EGCG
s likely the major constituent of GT responsible for the cytotox-
city reported here on HNSCC cell lines. One exception was  the
Q-20B cell line, where roughly twice the amount of GT in cate-
hin equivalents was required compared to EGCG to achieve IC50.
aken together, the current ﬁndings suggest that while cytotoxi-
ity of GT against HNSCC cell lines is likely attributable to EGCG
r related compounds, the antitumor activity of these compounds
ay  depend on the cell type. Moreover, in comparison to the
mmortalized cell line, HaCaT, all carcinoma lines required higher
oncentrations of GT to achieve the IC50, rather than selectively
illing the more malignant lines. Although the IC50 for MT  againsteated with AT for 48 h. (B) Effect of AT on cell death. Cells were treated with AT for
, SQ-20B). (C) Control (cells without treatment). Values are means ± SD from three
SCC-61 (74.8 M eq. (+) catechin) was  lower than that of HaCaT
(99.9 M eq. (+) catechin), other cytotoxicity values between these
two cell lines were similar (Table 1). On the other hand, a higher
concentration (266 M eq. (+) catechin) of MT  was necessary to
observe 100% growth inhibition of OSCC-3, more than two times
greater than that for SCC-61 cells (105.8 M eq. (+) catechin). These
differences in sensitivity to MT  indicate that these two cell lines
may  be at different stages of cancer malignancy. Interestingly, MT-
induced cytotoxicity exhibited a narrow range across the cell types
studied, regardless of end point. For instance, for HaCat cells, 50%
growth inhibition, total growth inhibition, and 50% lethal concen-
tration were between 84.2 and 118.7 M eq. (+) catechin.
When cytotoxicity of AT was  evaluated, OSCC-3 cells were found
to be very much more sensitive than other cell lines, including the
non-cancerous cell line HaCaT (Table 1). The chemical analysis of
AT has shown the presence of relatively little catechins compared
to GT, but instead a unique ﬂavonoid identiﬁed as ardisin [4]. There
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ay  be a relationship between the unique chemical composition of
T and its biological activity showing less cytotoxicity toward the
mmortalized cells HaCat.
Etoposide is an anticancer drug that inhibits DNA topoisomerase
I [21]. Etoposide caused accumulation in G2/M in HaCaT, SCC-61
nd SQ-20B, suggesting that the DNA repair process is activated
nd repairs the DNA damage by arresting the cell cycle in the G2/M
hase, conﬁrming a previous report that the p53 gene of both HaCaT
nd SQ-20B lines express a functional p53 mutant [16] and that
CC-61 cells contain wild p53 [9]. A similar observation was made
hen OSCC-3 cells were treated with etoposide, resulting in loss
f cell number in the G0/G1 phase. Although this cell line has not
een well characterized to date, it has a high proliferation rate and
ur data suggest that p53 is also mutated in this cell line.
Treatments with extracts and ECGC did alter cell cycle distribu-
ion although the changes were smaller, compared to etoposide.
he effect of the teas on cell cycle distribution varied among the
ell lines, although no extract arrested the cell cycle in all cell types
ested. Neither GT nor MT  signiﬁcantly altered the cell cycle in
aCaT cells at the concentrations studied. In contrast to their effects
n the other cell types, treatments with GT and EGCG resulted in
igniﬁcant cell cycle arrest in OSCC-3 cells (Fig. 2). When OSCC-
 cells were subjected to GT, the percentage of cells at G0/G1
tage declined from 66.1% to 41.3%, while cells at S and G2 phases
ncreased from 26.4 and 7.6 to 39.7 and 19.0, respectively. A simi-
ar effect was seen with EGCG, indicating that the GT components
hat were responsible for this effect are either EGCG or related
ompounds which function in the same manner. Furthermore,
reatments with AT resulted in a small but signiﬁcant G2/M arrest.
he majority of OSCC-3 cells treated with AT detached within 24 h,
nd a high proportion of cells were necrotic. This was not seen for
he other cell lines. While the mechanism is unclear, these cells are
learly more sensitive and future experiments to determine differ-
nces in responsiveness based upon genetic similarities/differences
s warranted.
When HaCaT cells were treated with AT for 24 h, approximately
7% of cells were at the G0/G1 phase, an approximately 20% increase
n the number of cells at this stage compared to untreated cells. This
arked increase in the G0/G1 phase indicates two  things. First, that
he mechanisms of cytotoxicity induced by AT is different from that
f the others tested exracts, at least for this particular cell line. Sec-
nd, HaCaT cells contain two heterozygous p53 mutations (exons
 and 8) [3] and has a more extended protein half-life than the wild
ype p53, and despite the mutations the p53 protein is still func-
ional and regulates cell cycle at the G0/G1 check-point [18]. The
resent ﬁnding conﬁrms that HaCaT indeed has a functional p53
rotein that arrest the cell cycle at G0/G1 to allow for repair of the
amage, and that AT can interfere with regulation of the cell cycle
or this particular cell line.
Both GT and EGCG are known to induce apoptosis in several
arcinoma cell types, but not in normal cells. For example, GT was
ro-apoptotic in SV40 virally transformed WI38 human ﬁbroblasts
WI38VA), while it had little or no effect on its normal counterpart,
I38 cells [7]. EGCG was capable of inducing apoptosis in HNSCC
ells, while it protected survival of normal cells [19]. Because of
hese reported properties of EGCG, this and its related compounds
ay  be effectively used for chemoprevention of HNSCC. Despite the
ro-apoptotic properties of reported EGCG [45], apoptosis of cells
as observed only when OSCC-3 were treated with this compound
Fig. 3). On the other hand, GT, in which EGCG is accounted for 10% of
otal polyphenols, was capable of inducing apoptosis in OSCC-3 and
CC-61. Induction of apoptosis was observed in GT-treated SQ-20B
ells, but the percent of the apoptotic cells was smaller, compared
o that of the two other cell lines. In contrast, treatment with GT
esulted in a lower number of apoptotic HaCaT cells, similar to that
f untreated cells. A study by Liu et al. has demonstrated that GT andgy Reports 3 (2016) 269–278
EGCG inhibited cell growth in three squamous cell lines (CAL-27,
SCC-25 and KB) via S and G2/M phase cell cycle arrest [30].
MT showed a signiﬁcant apoptotic activity against HaCaT
and SCC-61 cells with approximately 25 and 32% of apoptotic
cells respectively. No statistical differences were found between
untreated and MT-treated OSCC-3 and SQ-20B cells.
Unlike any other treatments, AT caused apoptosis in all HNSCC
and HaCaT cells. In fact, the number of apoptotic cells ranged from
35.1% (SQ-20B) to 48.9% (HaCaT). [34] indicated that malignancy
occurred in oral leukoplakia as a result of the avoidance of apo-
ptosis. Hence induction of apoptosis by AT treatment constitutes a
protective mechanism against carcinogenesis, via the elimination
of damaged cells or abnormal excess of HNSCC cells. Ardisia extract
and its constituents caused cytotoxicity, an accumulation of cells in
G1 (HaCaT) or G2/M (SCC-61, SQ-20B and OSCC-3), and apoptosis.
These results support previous observations linking ardisia aque-
ous extracts with chemopreventive effects, both in animal studies
and in folk medicine [14,24].
To further elucidate the mechanism of ardisia-induced apopto-
sis, caspase activation was investigated. Perhaps the most essential
ﬁnding during the apoptosis of cells exposed to AT was  that hinge
upon the activation of a family of cysteine proteases called caspases.
We used a phenotype analysis of caspases to detect apoptosis, by
the method of ﬂurorchrome-labeled inhibitors of caspases (FLICA),
which is relatively nontoxic to cells and penetrates through the
plasma membrane of live cells, binding to activated caspases in
apoptotic cells. FLICA is capable of simultaneously detect induction
of multiple caspases-1, 3, 4, 5, 7, 8 and 9, allowing the analysis of
apoptosis.
Interestingly, while the degree of caspases activation increased
over a period of time for OSCC-3 and SQ-20B treated with AT, it
was lower for SCC-61 cell lines after 24 h. Compared to these two
cell lines, SCC-61 appears to be at the least malignant stage. Fur-
thermore, the number of cells showing caspases activation was
lower than that of apoptotic cells with AT treatment. Several studies
have demonstrated that a variety of human malignancies, includ-
ing HNSC, contain subpopulation of cells [42,28], for this reason the
extent of the intracellular activation of caspases could be different
to the number of apoptotic cells. The current ﬁndings suggest the
presence of caspases-induced apoptotic pathways in HNSCC cell
lines treated with AT. Furthermore, the polyphenolic content of
AT (36.78 mg  eq. of (+) catechin/g DL) and its antioxidant capac-
ity (333.5 mol  Trolox/g DL) did not correlate with the cytotoxicity
activity.
In summary, the data indicate that all tested extracts were capa-
ble of inhibiting at least one line of HNSCC in a dose-dependent
manner. The effects of GT often, but not always, mimicked those
of EGCG suggesting a key role for this compound for prevention of
OSCC-3 and SCC-61 growth, but not for SQ-20B. EGCG was appar-
ently important for the effect on OSCC-3 and SCC-61 and was no
so effective against SQ-20B. Based on previous observations, the
inhibitory effect of AT on cell growth of OSCC-3 may be due to the
presence of quinone type compounds, such as ardisin [39]. Ardisia
extract exerted the greatest effect on apoptosis in all cell lines;
most probably by inducing caspases-dependent metabolic path-
ways. These results are promising, but more studies are needed
to better understand the underlying mechanism of action of these
extracts, as well as their speciﬁc anticarcinogenic potential depend-
ing on chemical composition and the cancer cell type. These
results suggest that AT has a different mechanism of protection
against cytotoxicity that is not related to its antioxidant capac-
ity. Although additional studies on the effects of ardisia extract
on cell cycle-associated protein are required in order to know the
molecular mechanism behind its anticancer activity and elucidate
which of the pathways of apoptosis (extrinsic, intrinsic or the per-
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orin/granzyme pathway) is activated by the complex mixture of
ompounds present in the extract.
Although bioavailability of aqueous extract constituents is low,
he concentrations used in the present study are relevant to normal
ea drinking because in addition to the direct contact between oral
quamous cells and AT, there may  also be a more prolonged cel-
ular interaction via the systemic circulation. In the context of the
resent ﬁndings, under normal preparation conditions the pheno-
ic concentration in A. compressa extract is 36.78 ± 1.07 mg  eq. (+)
atechin/g DL. Therefore, in practical terms, and based on the effec-
ive concentrations of catechin found in the present study, a person
ill have to ingest an approximate amount of 1 liter of extract/day
400 mg  eq. (+) catechin). After the consumption of 10–100 mg  of a
ingle phenolic compound, the maximum concentration in plasma
arely exceeds 1 mM [26]. Then it may  be possible that the anti-
ancer properties of AT could be due to a synergistic effect of the
ultiple constituents present in the extract, each of one has its
nique bioavailability.
. Conclusions
The fact that AT inhibits HSNCC cell proliferation makes this
otanical product a potential source of still unknown active sub-
tances that can be added to the arsenal of compounds that could be
sed as chemotherapeutic, chemomodulating or chemopreventive
gents. Therefore, AT deserves further studies in order to under-
tand the speciﬁc mechanism of action.
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